Twenty years of LASSBio, the laboratory of evaluation and synthesis of bioactive substances!
Saved in:
Main Author: | Elizabeth Igne Ferreira (Author) |
---|---|
Format: | Book |
Published: |
Universidade de São Paulo,
2014-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacokinetic Profile Evaluation of Novel Combretastatin Derivative, LASSBio-1920, as a Promising Colorectal Anticancer Agent
by: Celina de Jesus Guimarães, et al.
Published: (2023) -
Discovery of Putative Dual Inhibitor of Tubulin and EGFR by Phenotypic Approach on LASSBio-1586 Homologs
by: Gisele Barbosa, et al.
Published: (2022) -
Anti-atherogenic Effects of a New Thienylacylhydrazone Derivative, LASSBio-788, in Rats Fed a Hypercholesterolemic Diet
by: Nadia Alice Vieira da Motta, et al.
Published: (2013) -
Cytotoxic and Antiproliferative Activity of LASSBio-2208 and the Attempts to Determine Its Drug Metabolism and Pharmacokinetics In Vitro Profile
by: Raysa Magali Pillpe-Meza, et al.
Published: (2024) -
One year of BJPS!
by: Elizabeth Igne Ferreira
Published: (2009)